Lannett Co. Inc. | Ownership
Companies that own Lannett Co. Inc.
Telemus Capital LLC
8,111,281
20.85%
5,390
3.38%
06/30/2018
BlackRock Fund Advisors
4,140,263
10.64%
348,840
0%
06/30/2018
The Vanguard Group, Inc.
3,115,071
8.01%
3,766
0%
06/30/2018
LSV Asset Management
2,100,042
5.4%
43,031
0.01%
06/30/2018
Deerfield Management Company LP
1,801,353
4.63%
-939,724
0.28%
06/30/2018
SSgA Funds Management, Inc.
1,059,887
2.73%
-147,007
0%
06/30/2018
Morgan Stanley & Co. LLC
844,685
2.17%
-108,895
0.01%
06/30/2018
Frontier Capital Management Co. LLC
841,582
2.16%
-139,783
0.03%
06/30/2018
Dimensional Fund Advisors LP
822,267
2.11%
-4,129
0%
06/30/2018
Northern Trust Investments, Inc.
812,518
2.09%
11,756
0%
06/30/2018
| Address |
9000 State Road
Philadelphia Pennsylvania 19136
United States
|
|
Employees
|
- |
| Website |
http://www.lannett.com |
| Updated |
07/08/2019 |
| Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escltalopram oxalate; renitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA. |
